AMPH FDA calendar & decision history Amphastar Pharmaceuticals Inc. · no upcoming catalyst on file · 3 past FDA decisions
FDA decision history (3) Feb 24, 2026✓ Approved Ipratropium Bromide HFA Inhala Dec 15, 2025✓ Approved FDA decision Aug 11, 2025✓ Approved FDA decision See the full 2026 PDUFA calendar → This page aggregates AMPH's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.
Not affiliated with or endorsed by the FDA. pdufa.bio is an independent service; "FDA", "PDUFA", and all company, drug, and ticker names are used descriptively and remain the property of their owners. Informational and educational only — not investment advice. Data and historical statistics only; no trade recommendations and no individual-drug approval probabilities. Verify every date and outcome against primary FDA / SEC / company filings. © 2026 pdufa.bio